We are international
Donate
publications TEXT SIZE   
myeloma minute    back

Myeloma Minute
October 11, 2012
10.11.12

October 11, 2012
Share the Minute Facebook Tweet! Clinical Trials Donate to the IMF
 






Missed Today’s IMF Living Well Teleconference '10 Steps to Good Nutrition'? Listen here



ENDEAVOR Trial


Upcoming Events



x

6th Annual Comedy Celebration Tickets on sale now
Saturday, October 27, 2012


x

Be Bold, Be Bald!
Join the IMF team and wear a bald cap to honor those who battle cancer.
Friday, November 2, 2012



Sacramento Regional Community Workshop
Saturday, November 3, 2012


Myeloma Center Workshop at the Mayo Clinic Scottsdale, Arizona
Saturday, November 17, 2012
Research Update: MGUS Is Not Always Trouble Free
A recent paper in the journal Blood from the Mayo myeloma group draws attention to the fact that some patients with MGUS—Monoclonal Gammopathy of Undetermined Significance—can  have renal damage from the M-component, and even complete renal failure in some instances. They propose a new name for this subtype of patient: MGRS – Monoclonal Gammopathy of Renal Significance.  This is certainly helpful and draws attention to a whole range of clinical problems that can emerge from the effects of the M-component in serum and/or urine produced in MGUS patients. READ MORE

Cancellation of November’s FDA Advisory Committee for Pomalidomide: Bad News or Good?
The US Food and Drug Administration (FDA) has cancelled the planned November advisory committee (ODAC) meeting for Celgene's pomalidomide application. Brian G.M. Durie, MD, Chairman and Co-founder of the IMF, considers what the cancellation might mean for patients. READ MORE

x
‘Tom and Jerry’ Duo Brings Sense of Humor and Purpose to Advocating for Cancer Drug Parity
A big thank you to this month’s Advocate of the Month, Tom Glass, for his enthusiasm and energy from the beginning to the end of helping his legislator in Virginia recognize the importance of cancer drug parity legislation! “I saw this as an opportunity to do something of value that I could feel good about,” said Tom, who worked alongside Jerry Walton, leader of the Southeastern Virginia Multiple Myeloma Support Group, to meet with Rep. Rigell. Hence the nickname of this dynamic duo! READ MORE

Weighing Bedside Manner vs. Scientific Expertise When Selecting a Doctor
Blogger Pat Killingsworth writes that blind trust in the guidance of any physician can become problematic for a multiple myeloma patient, especially if the physician isn’t a specialist. “And even then, a second opinion is almost always a good idea whenever we find ourselves facing an important therapy crossroad.” READ MORE
 
 
Join Our Mailing List  
 

 

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
IMF Hotline: 800-452-2873 or 818-487-7455
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles